StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) stock

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.62−0.72 (-9.81%)

Close on Nov 17, 2026Market cap $399.15MP/E –Yield –

Eupraxia Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Eupraxia Pharmaceuticals's market cap was $418.63M on Nov 11, 2026, against $221.33M a year earlier. Over the last 4 years it ranged from $63.48M to $472.65M, with a median of $135.91M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$418.63M+55.6%
2025Dec 31, 2025$269.09M+211.1%
2024Dec 31, 2024$86.48M-3.7%
2023Dec 29, 2023$89.85M–

More Eupraxia Pharmaceuticals figures

See a number that looks wrong?